Abstract

Evidence-based methodology, in particular systematic review, is increasingly being applied in environmental, public, and occupational health to increase the transparency, comprehensiveness, and objectivity of the processes by which existing evidence is gathered, assessed, and synthesized in answering research questions. This development is also changing risk assessment practices and will impact the assessment of uncertainties in the evidence for risks to human health that are posed by exposure to chemicals. The potential of evidence-based methodology for characterizing uncertainties in risk assessment has been widely recognized, while its contribution to uncertainty reduction is yet to be fully elucidated. We therefore present some key aspects of the evidence-based approach to risk assessment, showing how they can contribute to the identification and the assessment of uncertainties. We focus on the pre-specification of an assessment method­ology in a protocol, comprehensive search strategies, study selection using predefined eligibility criteria, critical appraisal of individual studies, and an evidence integration and uncertainty characterization process based on certainty of evi­dence frameworks that are well-established in health care research. We also provide examples of uncertainty in risk assessment and discuss how evidence-based methodology could address those. This perspective, which neither claims to be comprehensive nor complete, is intended to stimulate discussion of the topic and to motivate detailed exploration of how evidence-based methodology contributes to characterization of uncertainties, and how it will lead to uncertainty reduction in the conduct of health risk assessment.

Highlights

  • ObjectivesThis handbook describes the methods and considerations for conducting a literature-based review of an agent, substance, mixture, or exposure circumstance selected for evaluation for listing in the Report on Carcinogens (RoC)

  • The evaluation of other relevant data considers whether there are convincing data demonstrating biologically plausible mechanisms or modes of action for cancer end points reported in humans and/or in experimental animals, or compelling data that the agent acts through mechanism(s) that do not operate in humans

  • The mechanisms by which a substance causes cancer are not completely known; mechanistic data have played a major role in the listing of several substances in the RoC

Read more

Summary

Objectives

This handbook describes the methods and considerations for conducting a literature-based review (i.e., cancer hazard evaluation) of an agent, substance, mixture, or exposure circumstance (collectively referred to as “substance”) selected for evaluation for listing in the Report on Carcinogens (RoC). The cancer hazard evaluation is captured in a RoC monograph, and this handbook serves as a resource for those preparing the monographs, including Office of the RoC (ORoC) staff, contractor support staff, and technical advisors. The approach to conducting the cancer hazard evaluation incorporates principles of systematic review, with the goal of increasing transparency (to the public and others) on how the conclusions are reached and strengthening consistency across evaluations of different substances. For each substance under review, a protocol is developed that adapts these methods for scientific issues specific to the substance

Background
Part A
Literature Search Strategy
Introduction and Objective
Screening and Selection of Literature
Data Sources
Part C: Evaluation of Human Exposure Data
Planning and Literature Search Strategy
Section Contents and Approach to Drafting
Synthesis of information and conclusions
Examples of Table Templates and Figures
Example table templates for property and exposure information
Examples of figures and graphs for visualizing exposure data
Part D: Evaluation of Human Cancer Studies
Initial Literature Review and Protocol Development
Identify potential covariates or co-exposures
Conduct background research on exposure and outcome metrics
Systematic Extraction of Data from the Epidemiologic Studies
Assessment of the Utility of the Individual Epidemiologic Studies
Overview of the approach for assessing study utility
Domains for evaluation of study quality and sensitivity
Domain-level judgment
Selection and attrition bias
Exposure misclassification
Outcome misclassification
Potential for confounding
Selective reporting
Analysis
Study sensitivity
Overall assessment of study utility
Cancer Hazard Evaluation
Evaluation of the evidence from the individual studies
Evaluation of potential confounding
Evaluating confidence in the study findings
Integration of the scientific evidence across human cancer studies
Study description tables
Study utility tables and figures
Methods to evaluate potential confounding
Potential confounding evaluation tables
Visualization of the evidence or findings across studies
Part E: Evaluation of Cancer Studies in Experimental Animals
Identification and Selection of the Relevant Literature
Systematic Extraction of Data from the Experimental Animal Studies
Assessment of the Utility of the Individual Studies in Experimental Animals
Steps in the assessment of study utility
Study utility evaluation
Study design
Exposure conditions
Reporting and analysis
External validity or interpretation
Integration of the scientific evidence across studies
Part F: Evaluation of Mechanistic and Other Relevant Data
Data Extraction and Evaluation of Study Quality
Evaluation of the Evidence
ADME and toxicokinetics
Mechanistic and other relevant data
Table templates
Evaluation
Conclusions
Examples of figures for mechanistic data
Introduction and Objectives
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.